{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T15:56:27Z","timestamp":1781538987529,"version":"3.54.5"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100016189","name":"Wesco Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016189","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s11095-026-04104-5","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T19:11:35Z","timestamp":1778008295000},"page":"1645-1654","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Raman Imaging-based Analysis of Drug Powder Dissolution on Calu-3 Cell Monolayers as a Mechanistic Predictor of Nasal Absorption"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4397-4353","authenticated-orcid":false,"given":"Tomoyuki","family":"Furubayashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryosuke","family":"Tatsuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maako","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nana","family":"Izumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamiko","family":"Kiyohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Moriyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,5]]},"reference":[{"key":"4104_CR1","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/S0090-9556(25)08752-5","volume":"17","author":"RN Bawarshi-Nassar","year":"1989","unstructured":"Bawarshi-Nassar RN, Hussain AA, Crooks PA. Nasal absorption and metabolism of progesterone and 17 beta-estradiol in the rat. Drug Metab Dispos. 1989;17:248\u201354. https:\/\/doi.org\/10.1016\/S0090-9556(25)08752-5.","journal-title":"Drug Metab Dispos"},{"key":"4104_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijpharm.2007.03.025","volume":"337","author":"S Grassin-Delyle","year":"2007","unstructured":"Grassin-Delyle S, Buenestado A, Naline E, Faisy C, Blouquit-Laye S, Couderc LJ, et al. Intranasal delivery: physicochemical and therapeutic aspects. Int J Pharm. 2007;337:1\u201324. https:\/\/doi.org\/10.1016\/j.ijpharm.2007.03.025.","journal-title":"Int J Pharm"},{"key":"4104_CR3","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1136\/bmj.290.6479.1390","volume":"290","author":"AE Pontiroli","year":"1985","unstructured":"Pontiroli AE, Alberetto M, Pozza G. Intranasal calcitonin and plasma calcium concentrations in normal subjects. Br Med J (Clin Res Ed). 1985;290:1390\u20131. https:\/\/doi.org\/10.1136\/bmj.290.6479.1390.","journal-title":"Br Med J (Clin Res Ed)"},{"key":"4104_CR4","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.npep.2012.07.001","volume":"46","author":"A Gossen","year":"2012","unstructured":"Gossen A, Hahn A, Westphal L, Prinz S, Schultz RT, Gr\u00fcnder G, et al. Oxytocin plasma concentrations after single intranasal oxytocin administration - a study in healthy men. Neuropeptides. 2012;46:211\u20135. https:\/\/doi.org\/10.1016\/j.npep.2012.07.001.","journal-title":"Neuropeptides"},{"key":"4104_CR5","first-page":"203","volume":"44","author":"SA Bernstein","year":"1997","unstructured":"Bernstein SA, Williford SL. Intranasal desmopressin-associated hyponatremia: a case report and literature review. J Fam Pract. 1997;44:203\u20138.","journal-title":"J Fam Pract"},{"key":"4104_CR6","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/s41577-021-00583-2","volume":"22","author":"EC Lavelle","year":"2021","unstructured":"Lavelle EC, Ward RW. Mucosal vaccines \u2014 fortifying the frontiers. Nat Rev Immunol. 2021;22:236\u201350. https:\/\/doi.org\/10.1038\/s41577-021-00583-2.","journal-title":"Nat Rev Immunol"},{"key":"4104_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-023-00717-8","volume":"8","author":"C Singh","year":"2023","unstructured":"Singh C, Verma S, Reddy P, Diamond MS, Curiel DT, Patel C, et al. Phase III pivotal comparative clinical trial of intranasal (iNCOVACC) and intramuscular COVID 19 vaccine (Covaxin\u00ae). NPJ Vaccines. 2023;8:125. https:\/\/doi.org\/10.1038\/s41541-023-00717-8.","journal-title":"NPJ Vaccines"},{"key":"4104_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14091870","volume":"14","author":"W Alabsi","year":"2022","unstructured":"Alabsi W, Eedara BB, Encinas-Basurto D, Polt R, Mansour HM. Nose-to-brain delivery of therapeutic peptides as nasal aerosols. Pharmaceutics. 2022;14:1870. https:\/\/doi.org\/10.3390\/pharmaceutics14091870.","journal-title":"Pharmaceutics"},{"key":"4104_CR9","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.ajps.2019.11.002","volume":"15","author":"C Wu","year":"2020","unstructured":"Wu C, Li B, Zhang Y, Chen T, Chen C, Jiang W, et al. Intranasal delivery of paeoniflorin nanocrystals for brain targeting. Asian J Pharm Sci. 2020;15:326\u201335. https:\/\/doi.org\/10.1016\/j.ajps.2019.11.002.","journal-title":"Asian J Pharm Sci"},{"key":"4104_CR10","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.ijpharm.2014.11.051","volume":"478","author":"W Cho","year":"2015","unstructured":"Cho W, Kim MS, Jung MS, Park J, Cha KH, Kim JS, et al. Design of salmon calcitonin particles for nasal delivery using spray-drying and novel supercritical fluid-assisted spray-drying processes. Int J Pharm. 2015;478:288\u201396. https:\/\/doi.org\/10.1016\/j.ijpharm.2014.11.051.","journal-title":"Int J Pharm"},{"key":"4104_CR11","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1007\/s11095-022-03247-5","volume":"39","author":"T Lapidot","year":"2022","unstructured":"Lapidot T, Bouhajib M, Faulknor J, Khan S, Temtsin Krayz G, Abrutzky C, et al. A novel faster-acting, dry powder-based, naloxone intranasal formulation for opioid overdose. Pharm Res. 2022;39:963\u201375. https:\/\/doi.org\/10.1007\/s11095-022-03247-5.","journal-title":"Pharm Res"},{"key":"4104_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejpb.2017.09.017","volume":"122","author":"S Kimura","year":"2018","unstructured":"Kimura S, Kiriyama A, Araki K, Yoshizumi M, Enomura M, Inoue D, et al. Novel strategy for improving the bioavailability of curcumin based on a new membrane transport mechanism that directly involves solid particles. Eur J Pharm Biopharm. 2018;122:1\u20135.","journal-title":"Eur J Pharm Biopharm"},{"key":"4104_CR13","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1208\/s12249-012-9822-3","volume":"13","author":"T Riley","year":"2012","unstructured":"Riley T, Christopher D, Arp J, Casazza A, Colombani A, Cooper A, et al. Challenges with developing in vitro dissolution tests for orally inhaled products (OIPs). AAPS PharmSciTech. 2012;13:978\u201389. https:\/\/doi.org\/10.1208\/s12249-012-9822-3.","journal-title":"AAPS PharmSciTech"},{"key":"4104_CR14","unstructured":"The Japanese Pharmacopoeia. 17th Edition, second supplement. ministry of health, labour and welfare, Japan; 2019."},{"key":"4104_CR15","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2023.2220149","volume":"15","author":"J Wang","year":"2023","unstructured":"Wang J, Chen J, Studts J, Wang G. In-line product quality monitoring during biopharmaceutical manufacturing using computational Raman spectroscopy. MAbs. 2023;15:2220149. https:\/\/doi.org\/10.1080\/19420862.2023.2220149.","journal-title":"MAbs"},{"key":"4104_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2025.125165","volume":"670","author":"CA Ortega-Z\u00fa\u00f1iga","year":"2025","unstructured":"Ortega-Z\u00fa\u00f1iga CA, Rom\u00e1n-Ospino AD, Gupta S, Omar T, Baranwal Y, Sanchez-Paternina A, et al. Real-time monitoring of small changes in powder blends and ejected tablets in a low-dose formulation with 1% w\/w of active pharmaceutical ingredient using Raman and near-infrared spatially resolved spectroscopy within a tablet press. Int J Pharm. 2025;670:125165. https:\/\/doi.org\/10.1016\/j.ijpharm.2025.125165.","journal-title":"Int J Pharm"},{"key":"4104_CR17","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-018-1201-2","volume":"20","author":"B Nagy","year":"2018","unstructured":"Nagy B, Farkas A, Borb\u00e1s E, Vass P, Nagy ZK, Marosi G. Raman spectroscopy for process analytical technologies of pharmaceutical secondary manufacturing. AAPS PharmSciTech. 2018;20:1. https:\/\/doi.org\/10.1208\/s12249-018-1201-2.","journal-title":"AAPS PharmSciTech"},{"key":"4104_CR18","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.ejpb.2020.05.018","volume":"153","author":"J Radtke","year":"2020","unstructured":"Radtke J, Kleinebudde P. Real-time monitoring of multi-layered film coating processes using Raman spectroscopy. Eur J Pharm Biopharm. 2020;153:43\u201351. https:\/\/doi.org\/10.1016\/j.ejpb.2020.05.018.","journal-title":"Eur J Pharm Biopharm"},{"key":"4104_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s40780-016-0038-7","volume":"2","author":"K Moriyama","year":"2016","unstructured":"Moriyama K, Takami Y, Uozumi N, Okuda A, Yamashita M, Yokomizo R, et al. Assessment of drug content uniformity of atropine sulfate triturate by liquid chromatography\u2013tandem mass spectrometry, X-ray powder diffraction, and Raman chemical imaging. J Pharm Health Care Sci. 2016;2:4. https:\/\/doi.org\/10.1186\/s40780-016-0038-7.","journal-title":"J Pharm Health Care Sci"},{"key":"4104_CR20","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1208\/s12248-009-9144-x","volume":"11","author":"A Dahan","year":"2009","unstructured":"Dahan A, Miller JM, Amidon GL. Prediction of solubility and permeability class membership: provisional BCS classification of the world\u2019s top oral drugs. AAPS J. 2009;11:740\u20136. https:\/\/doi.org\/10.1208\/s12248-009-9144-x.","journal-title":"AAPS J"},{"key":"4104_CR21","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1128\/AAC.41.12.2693","volume":"41","author":"ME Cavet","year":"1997","unstructured":"Cavet ME, West M, Simmons NL. Transepithelial transport of the fluoroquinolone ciprofloxacin by human airway epithelial Calu-3 cells. Antimicrob Agents Chemother. 1997;41:2693\u20138.","journal-title":"Antimicrob Agents Chemother"},{"key":"4104_CR22","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1248\/bpb.b16-00787","volume":"40","author":"A Tanaka","year":"2017","unstructured":"Tanaka A, Furubayashi T, Enomura Y, Hori T, Shimomura R, Maeda C, et al. Nasal drug absorption from powder formulations: effect of fluid volume changes on the mucosal surface. Biol Pharm Bull. 2017;40:212\u20139. https:\/\/doi.org\/10.1248\/bpb.b16-00787.","journal-title":"Biol Pharm Bull"},{"key":"4104_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2024.114612","volume":"207","author":"R Tatsuta","year":"2025","unstructured":"Tatsuta R, Tanaka A, Ogawara K, Higaki K, Furubayashi T, Sakane T. In vivo systemic evaluation of nasal drug absorption from powder formulations in rats. Eur J Pharm Biopharm. 2025;207:114612. https:\/\/doi.org\/10.1016\/j.ejpb.2024.114612.","journal-title":"Eur J Pharm Biopharm"},{"key":"4104_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics12010079","volume":"12","author":"T Furubayashi","year":"2020","unstructured":"Furubayashi T, Inoue D, Nishiyama N, Tanaka A, Yutani R, Kimura S, et al. Comparison of various cell lines and three-dimensional mucociliary tissue model systems to estimate drug permeability using an in vitro transport study to predict nasal drug absorption in rats. Pharmaceutics. 2020;12:79. https:\/\/doi.org\/10.3390\/pharmaceutics12010079.","journal-title":"Pharmaceutics"},{"key":"4104_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13030385","volume":"13","author":"M Trenkel","year":"2021","unstructured":"Trenkel M, Scherlie\u00df R. Nasal powder formulations: in-vitro characterisation of the impact of powders on nasal residence time and sensory effects. Pharmaceutics. 2021;13:5. https:\/\/doi.org\/10.3390\/pharmaceutics13030385.","journal-title":"Pharmaceutics"},{"key":"4104_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2023.123252","volume":"643","author":"P Henriques","year":"2023","unstructured":"Henriques P, Bicker J, Silva S, Doktorovov\u00e1 S, Fortuna A. Nasal-PAMPA: a novel non-cell-based high throughput screening assay for prediction of nasal drug permeability. Int J Pharm. 2023;643:123252. https:\/\/doi.org\/10.1016\/j.ijpharm.2023.123252.","journal-title":"Int J Pharm"},{"key":"4104_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2025.125392","volume":"674","author":"C Rigaut","year":"2025","unstructured":"Rigaut C, Deruyver L, Goole J, Lambert P, Haut B. A comprehensive analytical model for predicting drug absorption in the olfactory region: application to nose-to-brain delivery. Int J Pharm. 2025;674:125392. https:\/\/doi.org\/10.1016\/j.ijpharm.2025.125392.","journal-title":"Int J Pharm"},{"key":"4104_CR28","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1007\/s40005-023-00630-1","volume":"53","author":"P Henriques","year":"2023","unstructured":"Henriques P, Bicker J, Carona A, Miranda M, Vitorino C, Doktorovov\u00e1 S, et al. Amorphous nasal powder advanced performance: in vitro\/ex vivo studies and correlation with in vivo pharmacokinetics. J Pharm Investig. 2023;53:723\u201342. https:\/\/doi.org\/10.1007\/s40005-023-00630-1.","journal-title":"J Pharm Investig"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-026-04104-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11095-026-04104-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-026-04104-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T15:30:48Z","timestamp":1781537448000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11095-026-04104-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["4104"],"URL":"https:\/\/doi.org\/10.1007\/s11095-026-04104-5","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"7 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None declared.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}